Brief: Newron Pharmaceuticals: Current Cash Position At Approx EUR 60 Mln
11/12/2017 06:03
Dec 11 (Reuters) - NEWRON PHARMACEUTICALS NWRN.S :
* CURRENT CASH POSITION AFTER COMPLETING PRIVATE PLACEMENT
IN
SEPTEMBER 2017 IS APPROX EUR60M
Source text for Eikon: ID:nTENdlsmja
Further company coverage: NWRN.S
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 722 0920;))
Recent news on Newron Pharmaceuticals SpA
See all newsUS FDA flags four deaths in Newron's schizophrenia drug studies (updated)
US FDA cites 4 deaths in Newron's schizophrenia drug trial hold
Brief: Newron Says Topline Data From ENIGMA-TRS 1 Expected In Q1 2027
Brief: Newron Provides Update Following Type A Meeting With The FDA
Brief: Newron Reports Pause Of Enrollment Of New Study Participants In US Centers Of ENIGMA-TRS 2 Study